Search

Displaying results 1571 - 1580 of 10000 in total
  1. Drug

    Levamlodipine

    go.drugbank.com/drugs/DB09237
    ApprovedInvestigational

    [L1484] The names S-amlodipine and levamlodipine may be used interchangeably as both substances are the same, however.

    Mixtures: VOLTRAMOS 2.5 MG/160 MG FILM KAPLI TABLET, 28 ADET, VOLTRAMOS 5 MG/160 MG FILM KAPLI TABLET, 28 ADETProducts: ALENCAL®2.5 MG
  2. Drug

    Ganciclovir

    go.drugbank.com/drugs/DB01004
    ApprovedInvestigational

    An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

    Products: Cytovene, 500 mg, CYMEVENE FOR INJECTION 500 mg
  3. Drug

    Raltitrexed

    go.drugbank.com/drugs/DB00293
    ApprovedInvestigational

    It is an inhibitor of thymidylate synthase.

    Products: TOMUDEX ® 2 MG, TOMUDEX 2 MG FLAKON, 1 ADET
  4. Drug

    Deucravacitinib

    go.drugbank.com/drugs/DB16650
    ApprovedInvestigational

    [L43150] It was later approved by Health Canada in November 2022 [L44216] and by the European Medicines Agency in March 2023.[L45788]

    Products: SOTYKTU 6 mg film coated tablets, SOTYKTU® 6MG TABLETAS RECUBIERTAS
  5. Drug

    Midostaurin

    go.drugbank.com/drugs/DB06595
    ApprovedInvestigational

    It was initially characterized as a potential broad-spectrum antineoplastic agent, with activity toward diverse solid and hematopoietic tumors [A19108]. … It was approved on April 28, 2017 and has shown to increase the overall survival rate in patients with AML as an adjunct therapy along with chemotherapeutic agents.

    Products: RYDAPT (25 MG SOFT CAPSULES), RYDAPT 25 MG YUMUŞAK KAPSÜL, 112 ADET
  6. Drug

    Selpercatinib

    go.drugbank.com/drugs/DB15685
    ApprovedInvestigational

    [A202049, A202055, A202052, L13604] Although selpercatinib is currently still under investigation in clinical trial NCT04211337, it was granted accelerated FDA approval on May 8, 2020, for specific … RET-driven cancer indications.

    Categories: Rearranged during Transfection (RET) InhibitorsProducts: RETSEVMO ® 80 MG
  7. Drug

    Brompheniramine

    go.drugbank.com/drugs/DB00835
    Approved

    Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.

    Mixtures: M-end PE, M-end WcProducts: BOMEX TABLET 4 mg, Dimegan Inj 10mg/ml
  8. Drug

    Influenza A virus A/California/7/2009 (H1N1)-like hemagglutinin antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB14382
    Approved

    that it was previously exposed to. … Upon re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus

    Synonyms: Influenza A virus A/California/7/2009 (H1N1)-like hemagglutinin antigen (formaldehyde inactivated), Influenza a Virus A/california/7/2009(h1n1)-like Hemagglutinin Antigen (Formaldehyde Inactivated)
  9. Drug

    Parecoxib

    go.drugbank.com/drugs/DB08439
    ApprovedInvestigational

    A letter of non-approval for parecoxib was issued by the FDA in 2005. … As it is injectable, it can be used perioperatively when patients are unable to take oral medications.

    Products: DYNASTAT (POWDER FOR SOLUTION FOR INJECTION 40 MG/2ML), DYNASTAT ® 40 MG POLVO LIOFILIZADO PARA SOLUCION INYECTABLE
  10. Drug

    Propiverine

    go.drugbank.com/drugs/DB12278
    Approved

    Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB) . Overactive bladder (OAB) is a chronic condition of the lower urinary tract characterized...

    Products: MICTONORM UNO 30 MG HARTK., MİCTONORM 5 MG KAPLI TABLET, 98 ADET